Researchers trying to crack one of medicine's most perplexing unsolved mysteries can now keep abreast of late-breaking developments via the Schizophrenia Research Forum, a website launched this month ...

New research shows that schizophrenia is not a single disease, but a group of eight distinct disorders, each caused by changes in clusters of genes that lead to different sets of symptoms. The finding ...

Those affected by schizophrenia — directly or otherwise — are invited to a free community forum on the disease later this month. Hosted by the Schizophrenia Society of Ontario, ‘Breaking Down Walls: ...

This story originally appeared on the Schizophrenia Research Forum. 30 April 2008. Does a seven-year-old mouse model that mirrors schizophrenia traits bring good luck? The mouse, missing BACE1 (β-site ...

A public discussion on schizophrenia is taking place in Milton later this month. The Schizophrenia Society of Ontario is inviting Halton residents who are directly or indirectly affected by ...

A new study from Case Western Reserve University suggests a major shift in schizophrenia treatment: One that focuses on ...

About 200 people attended a mental health forum at the Franco-Manitoban Cultural Centre Wednesday night. "Facts and Myths about People Living with Schizophrenia and Psychosis" was organized by the ...

Li had spent seven years in the Selkirk Mental Health Centre before being moved to the Health Sciences Centre in February. He was approved to move to a group home earlier in May. The Manitoba ...

WALTHAM, Mass.--(BUSINESS WIRE)--FORUM Pharmaceuticals Inc. today announced topline results from two Phase 3 clinical trials in patients with cognitive impairment in schizophrenia (CIS). While ...

FORUM Pharmaceuticals announced topline results yesterday of its experimental drug encenicline, reporting that it missed primary endpoints in two Phase 3 trials of schizophrenia patients. The drug ...

Forum Pharmaceuticals has gotten out from under an FDA clinical hold on a Phase III schizophrenia study for its lead drug, but the company's efforts to develop the treatment for Alzheimer's disease ...